X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Expert Review of Neurotherapeutics

期刊標題檢索 最新評論: 沒有評論


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Expert Review of Neurotherapeutics]您好,您是該頁面的第 14281 位訪客。

期刊簡介
期刊名稱Expert Review of Neurotherapeutics Expert Review of Neurotherapeutics

According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is )
LetPub Score
6.3
50 ratings
Rate

Reputation
7.6

Influence
5.1

Speed
7.0

期刊簡稱EXPERT REV NEUROTHER
ISSN1473-7175
E-ISSN1744-8360
h-index63
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.000.9571.069
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Neurology (clinical)
Q182 / 400
Category: Medicine
Subcategory: Pharmacology (medical)
Q156 / 272
Category: Medicine
Subcategory: General Neuroscience
Q234 / 113

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points
官方網站http://www.tandfonline.com/loi/iern20
在線稿件提交https://mc.manuscriptcentral.com/ern
開放訪問No
出版商Taylor and Francis Ltd.
主題領域CLINICAL NEUROLOGY
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數108每年文章數趨勢
黃金OA百分比14.66%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CLINICAL NEUROLOGYSCIEQ273/277
PHARMACOLOGY & PHARMACYSCIEQ2105/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7175%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Expert Review of Neurotherapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    International Journal of NanomedicineH-index: 100

    CiteScore: 14.40
    Drug Delivery and Translational ResearchH-index: 27

    CiteScore: 11.70
    Chinese MedicineH-index: 34

    CiteScore: 7.90
    Drug Design Development and TherapyH-index: 48

    CiteScore: 9.00
    International Journal for Parasitology-Drugs and Drug ResistanceH-index: 27

    CiteScore: 7.90
    Chinese Journal of Natural MedicinesH-index: 27

    CiteScore: 7.50
    Journal of Global Antimicrobial ResistanceH-index: 16

    CiteScore: 8.70
    Australian PrescriberH-index: 21

    CiteScore: 3.80
    PEDIATRIC DRUGSH-index: 55

    CiteScore: 7.20
    Clinical Psychopharmacology and NeuroscienceH-index: 22

    CiteScore: 4.70
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Nanomedicine319611
    Drug Design Development and Therapy132316
    Chinese Medicine129944
    Chinese Journal of Natural Medicines101544
    Drug Delivery and Translational Research42335
    Iranian Journal of Basic Medical Sciences36011
    Journal of Global Antimicrobial Resistance33199
    PHARMACEUTICAL CHEMISTRY JOURNAL26689
    JOURNAL OF INFECTION AND CHEMOTHERAPY23402
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy15960
  •  

    Expert Review of Neurotherapeutics Expert Review of Neurotherapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    下一頁    末頁  (0/0)
  [Expert Review of Neurotherapeutics] 的評論撰寫評論
暫無評論。
首頁    上一頁    下一頁    末頁  (0/0)

開始撰寫 [Expert Review of Neurotherapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*